Watch the Video to Find Out how Kubermatic Kubernetes Platform Contributes to the Project.
In this talk Bill Mulligan from Kubermatic and Camille Marini from Owkin speak about the machine learning based drug discovery consortium “MELLODDY” and how it boosts drug discovery model development while addressing both security and privacy preservation concerns.
